AAM
Aberdeen Asset Management’s Pfizer PFE Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2017
Q2 | $181M | Buy |
5,387,738
+348,767
| +7% | +$11.7M | 0.6% | 32 |
|
2017
Q1 | $172M | Buy |
5,038,971
+106,693
| +2% | +$3.65M | 0.61% | 33 |
|
2016
Q4 | $160M | Sell |
4,932,278
-108,187
| -2% | -$3.51M | 0.61% | 32 |
|
2016
Q3 | $171M | Sell |
5,040,465
-72,583
| -1% | -$2.46M | 0.61% | 32 |
|
2016
Q2 | $180M | Sell |
5,113,048
-322,673
| -6% | -$11.4M | 0.67% | 31 |
|
2016
Q1 | $161M | Sell |
5,435,721
-192,300
| -3% | -$5.7M | 0.58% | 32 |
|
2015
Q4 | $188M | Sell |
5,628,021
-468,897
| -8% | -$15.6M | 0.64% | 30 |
|
2015
Q3 | $192M | Sell |
6,096,918
-210,186
| -3% | -$6.6M | 0.65% | 31 |
|
2015
Q2 | $211M | Sell |
6,307,104
-364,598
| -5% | -$12.2M | 0.61% | 30 |
|
2015
Q1 | $232M | Sell |
6,671,702
-418,615
| -6% | -$14.6M | 0.62% | 30 |
|
2014
Q4 | $221M | Sell |
7,090,317
-940,492
| -12% | -$29.3M | 0.55% | 30 |
|
2014
Q3 | $237M | Sell |
8,030,809
-557,755
| -6% | -$16.5M | 0.52% | 31 |
|
2014
Q2 | $255M | Buy |
8,588,564
+3,748,934
| +77% | +$111M | 0.53% | 31 |
|
2014
Q1 | $154M | Sell |
4,839,630
-213,679
| -4% | -$6.81M | 0.43% | 28 |
|
2013
Q4 | $154M | Buy |
5,053,309
+159,260
| +3% | +$4.85M | 0.43% | 28 |
|
2013
Q3 | $141M | Buy |
4,894,049
+1,515,968
| +45% | +$43.7M | 0.4% | 26 |
|
2013
Q2 | $94.7M | Buy |
+3,378,081
| New | +$94.7M | 0.3% | 27 |
|